Marshall Wace
NBIX icon

Marshall Wace’s Neurocrine Biosciences NBIX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.23M Buy
+41,649
New +$5.23M 0.01% 1025
2025
Q1
Sell
-2,425
Closed -$331K 2754
2024
Q4
$331K Buy
+2,425
New +$331K ﹤0.01% 2056
2024
Q2
Sell
-32,976
Closed -$4.55M 2551
2024
Q1
$4.55M Buy
+32,976
New +$4.55M 0.01% 909
2023
Q2
Sell
-162,683
Closed -$16.5M 2329
2023
Q1
$16.5M Buy
162,683
+132,237
+434% +$13.4M 0.04% 457
2022
Q4
$3.64M Buy
+30,446
New +$3.64M 0.01% 1146
2022
Q1
Sell
-10,553
Closed -$898K 3051
2021
Q4
$898K Buy
+10,553
New +$898K ﹤0.01% 1942
2021
Q1
Sell
-79,044
Closed -$7.58M 2386
2020
Q4
$7.58M Sell
79,044
-67,899
-46% -$6.51M 0.04% 396
2020
Q3
$14.1M Buy
+146,943
New +$14.1M 0.09% 201
2020
Q1
Sell
-4,395
Closed -$473K 1884
2019
Q4
$473K Sell
4,395
-62,171
-93% -$6.69M ﹤0.01% 1147
2019
Q3
$6M Buy
+66,566
New +$6M 0.05% 423
2019
Q2
Sell
-375,076
Closed -$33M 1631
2019
Q1
$33M Sell
375,076
-332,399
-47% -$29.3M 0.31% 55
2018
Q4
$50.5M Buy
707,475
+626,995
+779% +$44.8M 0.52% 29
2018
Q3
$9.9M Buy
+80,480
New +$9.9M 0.08% 305
2018
Q2
Sell
-8,144
Closed -$675K 794
2018
Q1
$675K Buy
+8,144
New +$675K 0.03% 302
2017
Q3
Sell
-10,093
Closed -$464K 394
2017
Q2
$464K Sell
10,093
-14,535
-59% -$668K 0.02% 247
2017
Q1
$1.06M Sell
24,628
-326,954
-93% -$14.1M 0.05% 200
2016
Q4
$13.6M Buy
351,582
+141,893
+68% +$5.49M 0.09% 259
2016
Q3
$10.6M Sell
209,689
-21,436
-9% -$1.09M 0.08% 271
2016
Q2
$10.5M Buy
+231,125
New +$10.5M 0.09% 230
2014
Q4
Sell
-51,860
Closed -$813K 904
2014
Q3
$813K Sell
51,860
-64,504
-55% -$1.01M 0.01% 578
2014
Q2
$1.73M Buy
+116,364
New +$1.73M 0.03% 418